Original Article
Detection and quantification of EGFR T790M mutation in liquid biopsies by droplet digital PCR
Translational Lung Cancer Research
2021;
10
(3)
:1200-1208
.
(30 March 2021)
Timing of chronic obstructive pulmonary disease diagnosis in lung cancer prognosis: a clinical and genomic-based study
Translational Lung Cancer Research
2021;
10
(3)
:1209-1220
.
(30 March 2021)
Low-level expression of necroptosis factors indicates a poor prognosis of the squamous cell carcinoma subtype of non-small-cell lung cancer
Translational Lung Cancer Research
2021;
10
(3)
:1221-1230
.
(30 March 2021)
Effect of prior therapy on tumor mutational burden in NSCLC
Translational Lung Cancer Research
2021;
10
(3)
:1231-1238
.
(30 March 2021)
Deep sequencing reveals the genomic characteristics of lung adenocarcinoma presenting as ground-glass nodules (GGNs)
Translational Lung Cancer Research
2021;
10
(3)
:1239-1255
.
(30 March 2021)
Titin mutation in circulatory tumor DNA is associated with efficacy to immune checkpoint blockade in advanced non-small cell lung cancer
Translational Lung Cancer Research
2021;
10
(3)
:1256-1265
.
(30 March 2021)
Inhaled corticosteroids and risk of lung cancer among chronic obstructive pulmonary disease patients: a comprehensive analysis of nine prospective cohorts
Translational Lung Cancer Research
2021;
10
(3)
:1266-1276
.
(30 March 2021)
Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer—an option for overcoming EGFR-TKI resistance
Translational Lung Cancer Research
2021;
10
(3)
:1277-1291
.
(30 March 2021)
Comprehensive molecular analysis of genomic profiles and PD-L1 expression in lung adenocarcinoma with a high-grade fetal adenocarcinoma component
Translational Lung Cancer Research
2021;
10
(3)
:1292-1304
.
(30 March 2021)
Validation of multivariable lung cancer risk prediction models for the personalized assignment of optimal screening frequency: a retrospective analysis of data from the German Lung Cancer Screening Intervention Trial (LUSI)
Translational Lung Cancer Research
2021;
10
(3)
:1305-1317
.
(30 March 2021)
Development of RECLS score to predict survival in lung cancer patients with malignant pleural effusion
Translational Lung Cancer Research
2021;
10
(3)
:1318-1326
.
(30 March 2021)
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma
Translational Lung Cancer Research
2021;
10
(3)
:1327-1337
.
(30 March 2021)
Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer
Translational Lung Cancer Research
2021;
10
(3)
:1338-1354
.
(30 March 2021)
Public opinion on implementing the National Lung Cancer Screening Program in Korea
Translational Lung Cancer Research
2021;
10
(3)
:1355-1367
.
(30 March 2021)
Examining the diagnostic pathway for lung cancer patients in Wales using discrete event simulation
Translational Lung Cancer Research
2021;
10
(3)
:1368-1382
.
(30 March 2021)
HER2 transmembrane domain mutation: comprehensive characteristics and real-world evidence of treatment response in Chinese lung adenocarcinoma
Translational Lung Cancer Research
2021;
10
(3)
:1383-1396
.
(30 March 2021)
Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors
Translational Lung Cancer Research
2021;
10
(3)
:1397-1407
.
(30 March 2021)
Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?
Translational Lung Cancer Research
2021;
10
(3)
:1408-1423
.
(30 March 2021)
Radiotherapy programs neutrophils to an antitumor phenotype by inducing mesenchymal-epithelial transition
Translational Lung Cancer Research
2021;
10
(3)
:1424-1443
.
(30 March 2021)
Isochorismatase domain-containing protein 1 (ISOC1) participates in DNA damage repair and inflammation-related pathways to promote lung cancer development
Translational Lung Cancer Research
2021;
10
(3)
:1444-1456
.
(30 March 2021)
circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p
Translational Lung Cancer Research
2021;
10
(3)
:1457-1473
.
(30 March 2021)
The effectiveness of three-dimensional reconstruction in the localization of multiple nodules in lung specimens: a prospective cohort study
Translational Lung Cancer Research
2021;
10
(3)
:1474-1483
.
(30 March 2021)
A signature of estimate-stromal-immune score-based genes associated with the prognosis of lung adenocarcinoma
Translational Lung Cancer Research
2021;
10
(3)
:1484-1500
.
(30 March 2021)
Increased detection of circulating tumor DNA by short fragment enrichment
Translational Lung Cancer Research
2021;
10
(3)
:1501-1511
.
(30 March 2021)
High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations
Translational Lung Cancer Research
2021;
10
(3)
:1512-1524
.
(30 March 2021)
Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib
Translational Lung Cancer Research
2021;
10
(3)
:1525-1535
.
(30 March 2021)
Review Article
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
Translational Lung Cancer Research
2021;
10
(3)
:1536-1556
.
(30 March 2021)
Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review
Translational Lung Cancer Research
2021;
10
(3)
:1557-1570
.
(30 March 2021)
Brief Report
A uniportal right upper lobectomy by three-arm robotic-assisted thoracoscopic surgery using the da Vinci (Xi) Surgical System in the treatment of early-stage lung cancer
Translational Lung Cancer Research
2021;
10
(3)
:1571-1575
.
(30 March 2021)
Case Report
Late-onset programmed cell death protein-1 inhibitor-induced pneumonitis after cessation of nivolumab or pembrolizumab in patients with advanced non-small cell lung cancer: a case series
Translational Lung Cancer Research
2021;
10
(3)
:1576-1581
.
(30 March 2021)
The clinical benefit of molecular re-assessments in management of progressive lung cancer
Translational Lung Cancer Research
2021;
10
(3)
:1582-1587
.
(30 March 2021)
Pulmonary fibrosis combined with lung cancer following lung transplantation: should we do more?
Translational Lung Cancer Research
2021;
10
(3)
:1588-1593
.
(30 March 2021)
